Novel Use of Pharmacogenetic Testing in the Identification of CYP2C9 Polymorphisms Related to NSAID‐Induced Gastropathy

Publisher： John Wiley & Sons Inc

E-ISSN： 1526-4637|16|5|866-869

ISSN： 1526-2375

Source： PAIN MEDICINE, Vol.16, Iss.5, 2015-05, pp. : 866-869

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Two cases of NSAID‐induced gastropathy and enteropathy of the ileum

By  

ANZ JOURNAL OF SURGERY, Vol. 85, Iss. 7-8, 2015-07 ,pp. : 584-585

John Wiley & Sons Inc

Access to resources Recommend Favorite

Interethnic and Intraethnic Variability of CYP2C8 and CYP2C9 Polymorphisms in Healthy Individuals

By García-Martín Elena  

Molecular Diagnosis & Therapy, Vol. 10, Iss. 1, 2006-01 ,pp. : 29-40

Adis International

Access to resources Recommend Favorite

Meaningful Use and Clinical Utility of Preemptive Pharmacogenetic Testing: (Re)View From a CYP2D6 Poor Metabolizer

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 97, Iss. 2, 2015-02 ,pp. : 119-121

John Wiley & Sons Inc

Access to resources Recommend Favorite

Individualized Therapy for Gastroesophageal Reflux Disease: Potential Impact of Pharmacogenetic Testing based on CYP2C19

By Furuta Takahisa  

Molecular Diagnosis & Therapy, Vol. 16, Iss. 4, 2012-08 ,pp. : 223-234

Adis International

Access to resources Recommend Favorite

Dicloxacillin induces CYP2C19, CYP2C9 and CYP3A4 in vivo and in vitro

By  

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 84, Iss. 3, 2018-03 ,pp. : 510-519

John Wiley & Sons Inc

Access to resources Recommend Favorite